Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Immunology and Microbiology
Peptides
53%
Infection
53%
Infectious Disease
52%
Autoimmunity
40%
Autoimmune Disease
39%
Systemic Lupus Erythematosus
27%
Antigen
23%
Prevalence
23%
Parasite
22%
Erythrocyte
21%
Plasmodium falciparum
19%
Malaria
18%
Plasmodium vivax
18%
COVID-19
18%
Infectious Agent
18%
Immune Response
17%
Uveitis
16%
In Vitro
16%
Human immunodeficiency virus
16%
Autoantibody
15%
Allele
15%
Susceptibility
15%
Binding Affinity
14%
Toxoplasmosis
14%
Inflammatory Arthritis
14%
Genetic Variability
12%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Plasmodium
10%
Epitope
9%
Cryptococcus neoformans
9%
Mycobacterium Tuberculosis
9%
Candida albicans
9%
Cytokine
8%
Candida
8%
T Cell
8%
Reticulocyte
8%
Merozoite
8%
Systemic Scleroderma
8%
Antifungal Susceptibility
7%
Lupus Erythematosus
7%
Wart Virus
7%
Multilocus Sequence Typing
7%
Immunogenicity
6%
Cohort Effect
6%
Zika virus
6%
Immune System
6%
Cardiovascular System
6%
T Cell Receptor
6%
Toxoplasma gondii
6%
Haplotype
6%
Epidemiology
6%
Microorganism
6%
Molecular Mimicry
5%
B Cell
5%
Coinfection
5%
Cryptococcus gattii
5%
Lineage
5%
Target Cell
5%
Host Cell
5%
Viral Disease
5%
Inflammation
5%
Cell Invasion
5%
Sporozoite
5%
Acquired Immune Deficiency Syndrome
5%
Rhoptry
5%
Virus
5%
Next Generation Sequencing
5%
Autoimmune Thyroiditis
5%
Minimum Inhibitory Concentration
5%
Medicine and Dentistry
Diseases
49%
Uveitis
42%
Systematic Review
36%
Meta-Analysis
25%
Prevalence
23%
Pediatrics
21%
Cross Sectional Study
19%
Adolescence
19%
Infection
17%
COVID-19
16%
Ocular Toxoplasmosis
13%
Biological Marker
10%
Odds Ratio
9%
Etiology
9%
Patient Referral
9%
Cohort Analysis
8%
Genetics
8%
Systemic Lupus Erythematosus
8%
Cohort Effect
8%
Autoimmunity
8%
Eye Disease
7%
Inflammation
7%
Quality of Life
7%
Toxoplasmosis
7%
Morbidity
7%
Health Care Cost
7%
Primary Health Care
7%
Optical Coherence Tomography
7%
Schizophrenia
7%
Public Health
6%
Education
6%
Mixed Infection
6%
Prospective Cohort Study
6%
Cardiovascular System
6%
Human immunodeficiency virus
6%
Histoplasmosis
6%
Randomized Controlled Trial
6%
Logistic Regression Analysis
6%
Body Mass Index
6%
Rheumatoid Arthritis
6%
Inflammatory Arthritis
6%
Pathogen
6%
Cardiorespiratory
5%
Oral
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Surgery
5%
Neuropathy
5%
Observational Study
5%
Mental Health
5%
Scoping Review
5%
Musculoskeletal Disease
5%
Intensive Care Unit
5%
Care Coordination
5%
Secondary Care
5%
Artificial Intelligence
5%
Retinal Vasculitis
5%
Toxoplasma gondii
5%
Visual Impairment
5%
Autoimmune Disease
5%
Laparoscopic Cholecystectomy
5%
Cardiometabolic Risk
5%
Malignant Neoplasm
5%
Keyphrases
Colombia
100%
Colombian
45%
Meta-analysis
22%
COVID-19
20%
Autoimmune Disease
19%
Uveitis
17%
Plasmodium Falciparum
15%
Latin America (LATAM)
15%
Risk Factors
14%
Systemic Lupus Erythematosus
11%
Ocular Toxoplasmosis
10%
Histoplasmosis
9%
Immune Response
9%
Bogota, Colombia
9%
High Activity Binding Peptides
9%
Colombian Patients
8%
Rheumatoid Arthritis
8%
Autoimmunity
8%
Physical Activity
8%
Toxoplasma Gondii (T. gondii)
8%
Malaria
8%
Odds Ratio
7%
Mycobacterium Tuberculosis (M. tb)
7%
95% Confidence Interval
7%
Older Adults
7%
Plasmodium Vivax
7%
Malaria Vaccine
6%
Health Systems
6%
Polyautoimmunity
6%
Narrative Review
6%
Metabolic Syndrome
6%
Schizophrenia
6%
Multiple Sclerosis
6%
Health Sciences
6%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
6%
Latin American
5%
Erythrocytes
5%
Healthcare Professionals
5%
Quality of Life
5%
Epilepsy
5%
Latin American Countries
5%
Autoantibodies
5%
P. Vivax
5%
CoMoS
5%
Systematic Literature Review
5%
Sjgren's Syndrome
5%
Polymorphism
5%
Disability
5%
Etiology
5%
Antifungal Susceptibility
5%
HLA-DRB1
5%
Red Blood Cells
5%
Immunogenic
5%
Public Health
5%